0	7	Cutting	cutting	JJ
8	12	edge	edge	NN
12	13	:	:	:
14	24	expression	expression	NN
25	27	of	of	IN
28	31	the	the	DT
32	34	NF	nf	NN
35	37	of	of	IN
38	47	activated	activate	VBN
48	49	T	t	NN
50	55	cells	cell	NNS
56	58	in	in	IN
59	70	eosinophils	eosinophil	NNS
70	71	:	:	:
72	82	regulation	regulation	NN
83	85	by	by	IN
86	90	IL-4	il-4	NN
91	94	and	and	CC
95	99	IL-5	il-5	NN
99	100	.	.	.

102	104	We	we	PRP
105	111	report	report	VBP
112	116	that	that	IN
117	123	NF-AT1	NF-AT1	NNP
124	127	and	and	CC
128	134	NF-AT4	NF-AT4	NNP
135	138	are	be	VBP
139	148	expressed	express	VBN
149	164	cytoplasmically	cytoplasmically	RB
165	167	in	in	IN
168	175	resting	rest	VBG
176	187	eosinophils	eosinophil	NNS
187	188	,	,	,
189	196	whereas	whereas	IN
197	203	NF-AT2	NF-AT2	NNP
204	207	and	and	CC
208	214	NF-AT3	NF-AT3	NNP
215	219	have	have	VBP
220	223	not	not	RB
224	228	been	be	VBN
229	233	seen	see	VBN
233	234	.	.	.

235	243	Likewise	likewise	RB
243	244	,	,	,
245	251	NF-AT1	NF-AT1	NNP
252	256	mRNA	mRNA	NNP
257	260	and	and	CC
261	267	NF-AT4	NF-AT4	NNP
268	272	mRNA	mRNA	NNP
273	277	have	have	VBP
278	282	been	be	VBN
283	291	detected	detect	VBN
292	294	in	in	IN
295	302	resting	rest	VBG
303	314	eosinophils	eosinophil	NNS
314	315	,	,	,
316	319	and	and	CC
320	325	their	their	PRP$
326	332	levels	level	NNS
333	336	can	can	MD
337	339	be	be	VB
340	353	significantly	significantly	RB
354	366	up-regulated	up-regulate	VBN
367	369	by	by	IN
370	373	the	the	DT
374	388	Th2-associated	th2-associated	JJ
389	398	cytokines	cytokine	NNS
399	403	IL-4	il-4	NN
404	407	and	and	CC
408	412	IL-5	il-5	NN
412	413	.	.	.

414	419	There	there	EX
420	422	is	be	VBZ
423	425	no	no	DT
426	436	detectable	detectable	JJ
437	442	NF-AT	NF-AT	NNP
443	450	protein	protein	NN
451	461	expression	expression	NN
462	464	in	in	IN
465	468	the	the	DT
469	475	nuclei	nucleus	NNS
476	478	of	of	IN
479	486	resting	rest	VBG
487	498	eosinophils	eosinophil	NNS
498	499	.	.	.

500	507	However	however	RB
508	514	NF-ATs	NF-AT	NNPS
515	521	appear	appear	VBP
522	524	in	in	IN
525	528	the	the	DT
529	535	nuclei	nucleus	NNS
536	538	of	of	IN
539	544	IL-4-	IL-4-	NNP
544	545	,	,	,
546	551	IL-5-	il-5-	NN
551	552	,	,	,
553	555	or	or	CC
556	576	ionomycin-stimulated	ionomycin-stimulated	JJ
577	588	eosinophils	eosinophil	NNS
588	589	.	.	.

590	594	Only	only	RB
595	601	NF-AT1	nf-at1	NN
602	605	and	and	CC
606	612	NF-AT4	nf-at4	NN
612	613	,	,	,
614	617	but	but	CC
618	621	not	not	RB
622	628	NF-AT2	nf-at2	NN
629	632	and	and	CC
633	639	NF-AT3	NF-AT3	NNP
639	640	,	,	,
641	645	have	have	VBP
646	658	translocated	translocate	VBN
659	663	into	into	IN
664	667	the	the	DT
668	674	nuclei	nucleus	NNS
675	677	in	in	IN
678	683	IL-4-	il-4-	NN
684	686	or	or	CC
687	702	IL-5-stimulated	il-5-stimulated	JJ
703	714	eosinophils	eosinophil	NNS
714	715	.	.	.

716	721	These	these	DT
722	730	findings	finding	NNS
731	740	delineate	delineate	VBP
741	742	a	a	DT
743	748	novel	novel	JJ
749	756	pathway	pathway	NN
757	759	in	in	IN
760	763	the	the	DT
764	772	cytokine	cytokine	NN
773	780	network	network	NN
781	783	in	in	IN
784	789	which	which	WDT
790	793	Th2	th2	NN
794	805	lymphocytes	lymphocyte	NNS
806	807	“	``	``
807	814	control	control	NN
814	815	”	''	''
816	827	eosinophils	eosinophil	NNS
828	831	via	via	IN
832	835	the	the	DT
836	843	release	release	NN
844	846	of	of	IN
847	851	IL-4	il-4	NN
852	855	and	and	CC
856	860	IL-5	il-5	NN
860	861	,	,	,
862	865	and	and	CC
866	876	activation	activation	NN
877	879	of	of	IN
880	885	NF-AT	NF-AT	NNP
886	888	in	in	IN
889	900	eosinophils	eosinophil	NNS
900	901	.	.	.

902	905	The	the	DT
906	914	findings	finding	NNS
915	919	also	also	RB
920	927	suggest	suggest	VBP
928	932	that	that	IN
933	934	a	a	DT
935	940	later	later	JJ
941	949	feedback	feedback	NN
950	951	“	``	``
951	958	talking	talk	VBG
958	959	”	''	''
960	963	may	may	MD
964	969	exist	exist	VB
970	977	between	between	IN
978	989	eosinophils	eosinophil	NNS
990	993	and	and	CC
994	997	Th2	th2	NN
998	1009	lymphocytes	lymphocyte	NNS
1009	1010	.	.	.